RESUMEN
The gut is home to our largest collection of microbes. The ability of the immune system to coevolve with the microbiota during postnatal life allows the host and microbiota to coexist in a mutually beneficial relationship. Failure to achieve or maintain equilibrium between a host and its microbiota has negative consequences for both intestinal and systemic health. In this Review, we consider the many cellular and molecular methods by which inflammatory responses are regulated to maintain intestinal homeostasis and the disease states that can ensue when this balance is lost.
Asunto(s)
Gastroenteritis/inmunología , Intestinos/inmunología , Intestinos/microbiología , Animales , Evolución Biológica , Gastroenteritis/fisiopatología , Homeostasis , Humanos , Enfermedades Inflamatorias del Intestino/inmunología , Enfermedades Inflamatorias del Intestino/microbiología , Mucosa Intestinal/inmunología , Mucosa Intestinal/microbiología , Intestinos/citología , Intestinos/fisiología , ProbióticosRESUMEN
Human noroviruses (huNoVs) cause epidemic acute gastroenteritis using histo-blood group antigens (HBGAs) as host receptors or attachment factors to initiate an infection. While most huNoVs have been shown to bind HBGAs, some known clinical isolates, such as GI.3 DSV and VA115, do not recognize any HBGAs and thus the molecular mechanism behind their infections remains elusive. In this study, we provided both phenotypic and structural evidence to show that huNoV DSV and VA115 recognize a group of glycans with terminal galactoses as ligands. First, through glycan array we found that both DSV and VA115 protruding (P) domain proteins bound two oligosaccharides that share common terminal galactoses. Then, by determination of the crystal structures of DSV/VA115 P proteins in complex with Galα1-3Galß1-4Glc and/or NA2 N-Glycan, respectively, we showed that the terminal galactose is the main saccharide recognized by the two viral proteins. Our data demonstrated that GI huNoVs can interact with non-HBGA glycans through their conserved galactose binding site, shedding light on the mechanism of huNoV adaptation through recognizing new glycan receptors to facilitate their widespread nature in human population. These findings are also of significance in strategy development for huNoV control and prevention, as well as development of antiviral drugs. IMPORTANCE Human noroviruses (huNoVs) are the most important viral pathogens causing epidemic acute gastroenteritis worldwide. Previous studies indicated that histo-blood group antigens (HBGAs) are critical host-susceptibility factors affecting huNoV host susceptibility, host range, and probably prevalence. However, certain huNoVs, such as GI.3 DSV and VA115, do not recognize any HBGAs. This implies that other unknown host factors might exist and the molecular mechanism underlying their host receptor recognition or attachment remains elusive. In this study, we found that purified capsid protruding domain proteins from two GI.3 huNoVs specifically bind two glycans that contain a common terminal galactose. We solved the crystal structures of the complexes at atomic resolution and validated the vital amino acids involved in glycan recognition. Our findings elucidate the mechanism of GI.3 huNoV-non-HBGA glycan interaction, which explains why GI.3 virus strains could not bind human HBGAs, paving a way to the prevention and treatment of huNoV-associated diseases.
Asunto(s)
Antígenos de Grupos Sanguíneos , Galactosa , Gastroenteritis , Norovirus , Sitios de Unión , Antígenos de Grupos Sanguíneos/metabolismo , Proteínas de la Cápside/metabolismo , Galactosa/metabolismo , Gastroenteritis/fisiopatología , Humanos , Norovirus/metabolismo , Unión ProteicaRESUMEN
BACKGROUND: A correlate of protection for rotavirus gastroenteritis would facilitate rapid assessment of vaccination strategies and the next generation of rotavirus vaccines. We aimed to quantify a threshold of postvaccine serum antirotavirus immunoglobulin A (IgA) as an individual-level immune correlate of protection against rotavirus gastroenteritis. METHODS: Individual-level data on 5074 infants in 9 GlaxoSmithKline Rotarix Phase 2/3 clinical trials from 16 countries were pooled. Cox proportional hazard models were fit to estimate hazard ratios (HRs) describing the relationship between IgA thresholds and occurrence of rotavirus gastroenteritis. RESULTS: Seroconversion (IgAâ ≥â 20 U/mL) conferred substantial protection against any and severe rotavirus gastroenteritis to age 1 year. In low child mortality settings, seroconversion provided near perfect protection against severe rotavirus gastroenteritis (HR,â 0.04; 95% confidence interval [CI], .01-.31). In high child mortality settings, seroconversion dramatically reduced the risk of severe rotavirus gastroenteritis (HR, 0.46; 95% CI, .25-.86). As IgA threshold increased, risk of rotavirus gastroenteritis generally decreased. A given IgA threshold provided better protection in low compared to high child mortality settings. DISCUSSION: Postvaccination antirotavirus IgA is a valuable correlate of protection against rotavirus gastroenteritis to age 1 year. Seroconversion provides an informative threshold for assessing rotavirus vaccine performance.
Asunto(s)
Anticuerpos Antivirales/sangre , Gastroenteritis/prevención & control , Inmunoglobulina A/inmunología , Infecciones por Rotavirus/prevención & control , Vacunas contra Rotavirus/inmunología , Rotavirus/inmunología , Femenino , Gastroenteritis/fisiopatología , Gastroenteritis/virología , Humanos , Lactante , Masculino , Ensayos Clínicos Controlados Aleatorios como Asunto , Infecciones por Rotavirus/fisiopatología , Vacunas contra Rotavirus/administración & dosificación , Índice de Severidad de la Enfermedad , Factores de Tiempo , Vacunas Atenuadas/administración & dosificación , Vacunas Atenuadas/inmunologíaRESUMEN
OBJECTIVE: This study first aims to assess the utility of ETCO2 levels in evaluating the severity of dehydration in adult patients that present to the ED with acute gastroenteritis. AGE. Second, it intends to evaluate the correlation between ETCO2 and several metabolic parameters: creatinine, pH, bicarbonate (HCO3), and bases excessive (BE). METHOD: This prospective study was conducted with AGE patients in the ED of a training and research hospital between June 2018 and April 2019 after approval of the local ethical-committee. The two groups were defined according to the severity of AGE: mild and non-mild groups. For both groups, ETCO2 levels were measured and recorded on admission of the patients. RESULTS: 87 patients were included in the analyses. The median of ETCO2 values was found as lower in non-mild group than mild group; 30 (25-35) & 39 (33-34), respectively (pâ¯<â¯0.001). In ROC analysis for distinguishing between the both groups, the AUC value was found to be 0.988 and the best cut-off level was found as 33.5 with 95% sensitivity and 93% specificity. In addition, strong negative correlation between ETCO2 and creatinine (pâ¯<â¯0.001, r: -0.771) were found. CONCLUSION: ETCO2 levels decreased in the non-mild group of AGE patients; it could be useful to distinguish the mild group from the non-mild group. ETCO2 could be a reliable marker in predicting AKI in the management of AGE patients.
Asunto(s)
Análisis de los Gases de la Sangre/estadística & datos numéricos , Dióxido de Carbono/análisis , Deshidratación/diagnóstico , Gastroenteritis/clasificación , Adulto , Anciano , Área Bajo la Curva , Biomarcadores/análisis , Biomarcadores/sangre , Análisis de los Gases de la Sangre/métodos , Dióxido de Carbono/sangre , Deshidratación/clasificación , Deshidratación/fisiopatología , Diarrea/complicaciones , Diarrea/etiología , Diarrea/fisiopatología , Puntuación de Alerta Temprana , Servicio de Urgencia en Hospital/organización & administración , Servicio de Urgencia en Hospital/estadística & datos numéricos , Femenino , Gastroenteritis/diagnóstico , Gastroenteritis/fisiopatología , Humanos , Masculino , Persona de Mediana Edad , Valor Predictivo de las Pruebas , Estudios Prospectivos , Curva ROC , Estadísticas no ParamétricasRESUMEN
On 16 March 2018, a nursing home notified a possible acute gastroenteritis outbreak that affected 11 people. Descriptive and case-control studies and analysis of clinical and environmental samples were carried out to determine the characteristics of the outbreak, its aetiology, the transmission mechanism and the causal food. The extent of the outbreak in and outside the nursing home was determined and the staff factors influencing propagation were studied by multivariate analysis. A turkey dinner on March 14 was associated with the outbreak (OR 4.22, 95% CI 1.11-16.01). Norovirus genogroups I and II were identified in stool samples. The attack rates in residents, staff and household contacts of staff were 23.49%, 46.22% and 22.87%, respectively. Care assistants and cleaning staff were the staff most frequently affected. Cohabitation with an affected care assistant was the most important factor in the occurrence of cases in the home (adjusted OR 6.37, 95% CI 1.13-36.02). Our results show that staff in close contact with residents and their household contacts had a higher risk of infection during the norovirus outbreak.
Asunto(s)
Infecciones por Caliciviridae/epidemiología , Trazado de Contacto/métodos , Brotes de Enfermedades , Gastroenteritis/epidemiología , Norovirus/aislamiento & purificación , Casas de Salud , Adulto , Anciano , Análisis de Varianza , Infecciones por Caliciviridae/etiología , Estudios de Casos y Controles , Femenino , Enfermedades Transmitidas por los Alimentos/diagnóstico , Enfermedades Transmitidas por los Alimentos/epidemiología , Gastroenteritis/etiología , Gastroenteritis/fisiopatología , Humanos , Control de Infecciones/métodos , Modelos Logísticos , Masculino , Persona de Mediana Edad , Análisis Multivariante , Personal de Enfermería/estadística & datos numéricos , Prevalencia , Estudios Retrospectivos , Medición de Riesgo , Índice de Severidad de la Enfermedad , España/epidemiologíaRESUMEN
This JAMA Insights Clinical Update discusses the symptoms, diagnosis, and management of eosinophilic gastrointestinal diseases.
Asunto(s)
Eosinofilia , Gastroenteritis , Humanos , Enteritis , Eosinofilia/diagnóstico , Eosinofilia/etiología , Eosinofilia/fisiopatología , Gastritis/diagnóstico , Gastritis/etiología , Gastritis/fisiopatología , Esofagitis Eosinofílica/diagnóstico , Esofagitis Eosinofílica/etiología , Esofagitis Eosinofílica/fisiopatología , Gastroenteritis/diagnóstico , Gastroenteritis/etiología , Gastroenteritis/fisiopatologíaRESUMEN
Norovirus (NoV) infection is the most common cause of acute gastroenteritis in humans of all ages worldwide. When cats are experimentally infected with feline norovirus (FNoV), they develop symptoms of acute gastroenteritis. Therefore, FNoV infection may serve as an animal model for the disease caused by human norovirus infection. In this study, we examined whether FNoV of cats infected with genogroup GVI are protected from reinfection with the same strain. The blood anti-FNoV IgG level was inversely correlated with the viral load in stool samples and the clinical score of FNoV-infected cats, but complete prevention of reinfection was not observed. These findings were similar to the results of a reinfection experiment with NoV in human volunteers.
Asunto(s)
Infecciones por Caliciviridae/fisiopatología , Proteínas de la Cápside/genética , Gastroenteritis/fisiopatología , Norovirus/genética , ARN Viral/genética , Esparcimiento de Virus , Animales , Infecciones por Caliciviridae/diagnóstico , Infecciones por Caliciviridae/inmunología , Infecciones por Caliciviridae/virología , Gatos , ADN Complementario/genética , Heces/virología , Gastroenteritis/diagnóstico , Gastroenteritis/inmunología , Gastroenteritis/virología , Norovirus/clasificación , Norovirus/crecimiento & desarrollo , Filogenia , Recurrencia , Análisis de Secuencia de ADN , Organismos Libres de Patógenos Específicos , Carga ViralRESUMEN
Currently recommended management of acute gastroenteritis is supportive. Although the affected children habitually have vomiting, recommendations do not focus on the correction of this symptom. In this condition, elevated ketone bodies and stimuli initiated by gut mucosa damage produced by the enteral pathogen likely underlay nausea and vomiting. As compared to 0.9% saline, intravenous administration of a dextrose-containing bolus of 0.9% saline is associated with a greater reduction of circulating ketones and a shorter duration of nausea and vomiting. Nonetheless, this treatment strategy is not followed by a lower rate of hospitalization. CONCLUSION: Well-designed investigations suggest that antagonists of the type 3 serotonin receptor, most frequently oral ondansetron, reduce the rate of vomiting, improve the tolerance of oral rehydration, and reduce the need for intravenous rehydration. What is Known: ⢠Although children with gastroenteritis habitually have vomiting, current recommendations do not focus on the correction of this symptom. What is New: ⢠Recently acquired evidence supports the prescription of ondansetron, an antagonist of the type 3 serotonin receptor, to increase the success rate of oral rehydration therapy.
Asunto(s)
Gastroenteritis/fisiopatología , Náusea/terapia , Vómitos/terapia , Enfermedad Aguda , Antieméticos/uso terapéutico , Terapia Combinada , Fluidoterapia , Gastroenteritis/terapia , Humanos , Náusea/etiología , Ondansetrón/uso terapéutico , Resultado del Tratamiento , Vómitos/etiologíaRESUMEN
OBJECTIVE: To assess the severity of acute gastroenteritis in paediatric population. METHODS: This observational cross-sectional study was conducted at 93 randomly selected outpatient centres with paediatric practice across Pakistan between July 2014 and January 2015, involving children between 3 to 48 months of age suffering from acute gastroenteritis. The severity of acute gastroenteritis was measured using Modified Vesikari Score. SPSS 18 was used for data analysis. RESULTS: There were 1,756subjects having a mean age of 18.6±12.0 months. There were 220(12.52%) children ?6 months out of whom 73(33%) were exclusively breastfed. Most children had moderate 1,041(59.3%) and severe 403(22.9%) acute gastroenteritis. Overall 1,401(79.8%) carers were females, of whom 1,080(77.1%) were mothers with a mean age of 29.7±6.7 years. Oral rehydration solution 1,357(77.3%), plain water 1,083(61.7%), antipyretics 783(44.6%) and anti-diarrhoeals 645(36.7%) were most common medicines administered at home by the carers. Mean duration between gastroenteritis onset and seeking consultation was 2.7±1.7 days. Most common treatment provided by physicians were oral rehydration solution 1,451(82.6%), antibiotic 1,294(73.7%) and probiotic 1,105(62.9%). Worsening of symptoms 1,152(65.6%) was the most common reason for seeking consultation. CONCLUSIONS: Most children assessed with acute gastroenteritis showed moderate to severe disease symptoms.|.
Asunto(s)
Gastroenteritis/fisiopatología , Antibacterianos/uso terapéutico , Antidiarreicos/uso terapéutico , Antipiréticos/uso terapéutico , Preescolar , Estudios Transversales , Agua Potable , Femenino , Fluidoterapia/métodos , Gastroenteritis/terapia , Humanos , Lactante , Masculino , Pakistán , Aceptación de la Atención de Salud , Probióticos/uso terapéutico , Índice de Severidad de la EnfermedadRESUMEN
Sensory neurons in the gastrointestinal tract have multifaceted roles in maintaining homeostasis, detecting danger and initiating protective responses. The gastrointestinal tract is innervated by three types of sensory neurons: dorsal root ganglia, nodose/jugular ganglia and intrinsic primary afferent neurons. Here, we examine how these distinct sensory neurons and their signal transducers participate in regulating gastrointestinal inflammation and host defence. Sensory neurons are equipped with molecular sensors that enable neuronal detection of diverse environmental signals including thermal and mechanical stimuli, inflammatory mediators and tissue damage. Emerging evidence shows that sensory neurons participate in host-microbe interactions. Sensory neurons are able to detect pathogenic and commensal bacteria through specific metabolites, cell-wall components, and toxins. Here, we review recent work on the mechanisms of bacterial detection by distinct subtypes of gut-innervating sensory neurons. Upon activation, sensory neurons communicate to the immune system to modulate tissue inflammation through antidromic signalling and efferent neural circuits. We discuss how this neuro-immune regulation is orchestrated through transient receptor potential ion channels and sensory neuropeptides including substance P, calcitonin gene-related peptide, vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Recent studies also highlight a role for sensory neurons in regulating host defence against enteric bacterial pathogens including Salmonella typhimurium, Citrobacter rodentium and enterotoxigenic Escherichia coli. Understanding how sensory neurons respond to gastrointestinal flora and communicate with immune cells to regulate host defence enhances our knowledge of host physiology and may form the basis for new approaches to treat gastrointestinal diseases.
Asunto(s)
Gastroenteritis/fisiopatología , Tracto Gastrointestinal/inervación , Células Receptoras Sensoriales/fisiología , Fenómenos Fisiológicos Bacterianos , Gastroenteritis/inmunología , Gastroenteritis/microbiología , Humanos , Canales Iónicos/fisiología , Neuropéptidos/fisiologíaRESUMEN
BACKGROUND: The aim of this study was to investigate the frequency of elevated alanine (ALT) and aspartate aminotransferase (AST) levels in children with rotavirus positive and negative gastroenteritis as well as the average time to normalization of liver enzymes. METHODS: Into the study 298 patients with rotavirus positive and 321 patients with rotavirus negative gastroenteritis were enrolled. RESULTS: Mean AST (56.9±2.1 and 40.2±0.9 U/L, respectively, P=0.000) and ALT (33.1±1.7 and 22.4±0.8 U/L, respectively, P=0.000) levels were significantly higher in the rotavirus positive than rotavirus negative patients. Logistic regression analysis showed that rotavirus positivity was significant independent factor for both AST and ALT elevation. Severity of gastroenteritis was another significant independent factor for ALT elevation. The average transaminase normalization time for AST and ALT levels were similar both rotavirus positive and negative groups. CONCLUSIONS: Rotavirus positivity and severity of gastroenteritis were independent risk factors for elevated ALT levels in children with gastroenteritis.
Asunto(s)
Alanina Transaminasa/sangre , Aspartato Aminotransferasas/sangre , Gastroenteritis/enzimología , Infecciones por Rotavirus/enzimología , Enfermedad Aguda , Estudios de Casos y Controles , Niño , Preescolar , Femenino , Gastroenteritis/fisiopatología , Gastroenteritis/virología , Humanos , Lactante , Modelos Logísticos , Masculino , Estudios Prospectivos , Factores de Riesgo , Infecciones por Rotavirus/complicaciones , Índice de Severidad de la Enfermedad , Factores de TiempoRESUMEN
In several gut inflammatory or cancer diseases, cell-cell interactions are compromised, and an increased cytoplasmic expression of ß-catenin is observed. Over the last decade, numerous studies provided compelling experimental evidence that the loss of cadherin-mediated cell adhesion can promote ß-catenin release and signaling without any specific activation of the canonical Wnt pathway. In the present work, we took advantage of the ability of lipofectamine-like reagent to cause a synchronous dissociation of adherent junctions in cells isolated from the rat enteric nervous system (ENS) for obtaining an in vitro model of deregulated ß-catenin signaling. Under these experimental conditions, a green fluorescent protein Wnt reporter plasmid called ΔTop_EGFP3a was successfully tested to screen ß-catenin stabilization at resting and primed conditions with exogenous Wnt3a or lipopolysaccharide (LPS). ΔTop_EGFP3a provided a reliable and strong fluorescent signal that was easily measurable and at the same time highly sensitive to modulations of Wnt signaling following Wnt3a and LPS stimulation. The reporter gene was useful to demonstrate that Wnt3a exerts a protective activity in the ENS from overstimulated Wnt signaling by promoting a downregulation of the total ß-catenin level. Based on this evidence, the use of ΔTop_EGFP3a reporter plasmid could represent a more reliable tool for the investigation of Wnt and cross-talking pathways in ENS inflammation.
Asunto(s)
Sistema Nervioso Entérico , Gastroenteritis/genética , Genes Reporteros/genética , Plásmidos/genética , Vía de Señalización Wnt/genética , Animales , Adhesión Celular/efectos de los fármacos , Membrana Celular/patología , Regulación hacia Abajo/efectos de los fármacos , Fluorescencia , Gastroenteritis/fisiopatología , Proteínas Fluorescentes Verdes , Indicadores y Reactivos , Lípidos , Lipopolisacáridos/farmacología , Ratas , Ratas Sprague-Dawley , Proteína Wnt3A/farmacología , beta Catenina/metabolismoRESUMEN
Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) have been implicated in the pathogenesis of gastrointestinal diseases, such as rotavirus gastroenteritis (GE). Kinetics of these biomarkers were examined in paired serum samples collected from bacterial enteritis patients with Campylobacter (n = 2) and Salmonella (n = 4) and viral GE patients with rotavirus (n = 27), norovirus (n = 25), and adenovirus (n = 11). At the time of hospital admission, all viral GE patients demonstrated increased MMP-9 and decreased MMP-2 and TIMP-2 serum levels. In contrast to viral GE patients, serum MMP-9 levels were not elevated at the time of hospital admission but elevated at the time of discharge; serum MMP-2 and TIMP-2 levels were decreased both at the time of admission and discharge in bacterial enteritis patients. Interestingly, the kinetics of serum MMP-2, MMP-9, and TIMP-2 levels were similar among the viral GE patients but distinct from bacterial enteritis patients. Thus, the involvement of MMPs and TIMPs in the pathophysiology of gastrointestinal symptoms likely varies depending on the etiological agent. Further studies are required to verify whether the extent of the bacterial enteritis or age of the patients influences these serum biomarkers. J. Med. Virol. 88:1341-1346, 2016. © 2016 Wiley Periodicals, Inc.
Asunto(s)
Gastroenteritis/microbiología , Gastroenteritis/fisiopatología , Metaloproteinasa 2 de la Matriz/metabolismo , Metaloproteinasa 9 de la Matriz/metabolismo , Inhibidor Tisular de Metaloproteinasa-2/metabolismo , Adenoviridae/aislamiento & purificación , Adenoviridae/patogenicidad , Infecciones por Adenoviridae/epidemiología , Infecciones por Adenoviridae/virología , Biomarcadores/sangre , Infecciones por Caliciviridae/epidemiología , Infecciones por Caliciviridae/virología , Campylobacter/aislamiento & purificación , Campylobacter/patogenicidad , Infecciones por Campylobacter/epidemiología , Infecciones por Campylobacter/virología , Niño , Preescolar , Femenino , Gastroenteritis/enzimología , Gastroenteritis/virología , Humanos , Lactante , Cinética , Masculino , Metaloproteinasa 2 de la Matriz/sangre , Metaloproteinasa 9 de la Matriz/sangre , Norovirus/aislamiento & purificación , Norovirus/patogenicidad , Rotavirus/aislamiento & purificación , Rotavirus/patogenicidad , Infecciones por Rotavirus/epidemiología , Infecciones por Rotavirus/virología , Salmonella/aislamiento & purificación , Salmonella/patogenicidad , Infecciones por Salmonella/epidemiología , Infecciones por Salmonella/virología , Inhibidor Tisular de Metaloproteinasa-2/sangreRESUMEN
PURPOSE OF REVIEW: The study reviews recent publications that build on previous studies showing that acute enteric infection can produce persistent dysfunction in the lower gut (postinfectious irritable bowel syndrome) and proximal gut (postinfectious functional dyspepsia). The review addresses risk factors, the pathophysiological basis of persistent gut dysfunction, and the factors that initiate and maintain it. RECENT FINDINGS: Recent work has identified several loci of host genetic predisposition to these syndromes that focus attention on host immune responses that may lead to gut dysfunction, including changes in intestinal barrier function and cytokine responses to the initial infection. Human and animal studies identify changes in the serotonergic and cannabinoid pathways regulating visceral pain responses and gut motility. Recent work has also focused attention on the putative role of the intestinal microbiota or dysbiosis in maintaining gut dysfunction and this is reviewed in depth. SUMMARY: The development of long-term consequences following an acute episode of gastroenteritis reflects a convergence of host factors that include genetic predisposition and psychological factors, as well as the development of intestinal dysbiosis. It is anticipated that future research will generate biomarkers of susceptibility as well as novel microbiota-directed preventive and therapeutic strategies.
Asunto(s)
Diarrea/etiología , Disbiosis/etiología , Gastroenteritis/complicaciones , Tracto Gastrointestinal/fisiopatología , Síndrome del Colon Irritable/fisiopatología , Diarrea/inmunología , Diarrea/microbiología , Disbiosis/inmunología , Disbiosis/fisiopatología , Gastroenteritis/inmunología , Gastroenteritis/fisiopatología , Motilidad Gastrointestinal/inmunología , Tracto Gastrointestinal/inmunología , Tracto Gastrointestinal/microbiología , Predisposición Genética a la Enfermedad , Humanos , Inmunidad Mucosa , Síndrome del Colon Irritable/etiología , Síndrome del Colon Irritable/inmunología , Síndrome del Colon Irritable/microbiología , Pronóstico , Factores de RiesgoRESUMEN
AIMS: Metformin is the most widely used oral anti-diabetes agent and has considerable benefits over other therapies, yet 20-30% of people develop gastrointestinal side effects, and 5% are unable to tolerate metformin due to the severity of these side effects. The mechanism for gastrointestinal side effects and their considerable inter-individual variability is unclear. We have recently shown the association between organic cation transporter 1 (OCT1) variants and severe intolerance to metformin in people with Type 2 diabetes. The aim of this study was to explore the association of OCT1 reduced-function polymorphisms with common metformin-induced gastrointestinal side effects in Type 2 diabetes. METHODS: This prospective observational cohort study included 92 patients with newly diagnosed Type 2 diabetes, incident users of metformin. Patients were genotyped for two common loss-of-function variants in the OCT1 gene (SLC22A1): R61C (rs12208357) and M420del (rs72552763). The association of OCT1 reduced-function alleles with gastrointestinal side effects was analysed using logistic regression. RESULTS: Forty-three patients (47%) experienced gastrointestinal adverse effects in the first 6 months of metformin treatment. Interestingly, the number of OCT1 reduced-function alleles was significantly associated with over two-fold higher odds of the common metformin-induced gastrointestinal side effects (odds ratio = 2.31, 95% confidence interval 1.07-5.01, P = 0.034). CONCLUSIONS: In conclusion, we showed for the first time the association between OCT1 variants and common metformin-induced gastrointestinal side effects. These results confirm recent findings related to the role of OCT1 in severe metformin intolerance, and suggest that high inter-individual variability in mild/moderate and severe gastrointestinal intolerance share a common underlying mechanism. These data could contribute to more personalized and safer metformin treatment.
Asunto(s)
Diabetes Mellitus Tipo 2/tratamiento farmacológico , Gastroenteritis/inducido químicamente , Predisposición Genética a la Enfermedad , Hipoglucemiantes/efectos adversos , Metformina/efectos adversos , Transportador 1 de Catión Orgánico/genética , Polimorfismo Genético , Anciano , Alelos , Sustitución de Aminoácidos , Bosnia y Herzegovina , Estudios de Cohortes , Femenino , Gastroenteritis/genética , Gastroenteritis/metabolismo , Gastroenteritis/fisiopatología , Eliminación de Gen , Estudios de Asociación Genética , Humanos , Hipoglucemiantes/uso terapéutico , Masculino , Metformina/uso terapéutico , Persona de Mediana Edad , Transportador 1 de Catión Orgánico/metabolismo , Estudios Prospectivos , Índice de Severidad de la Enfermedad , Caracteres SexualesRESUMEN
BACKGROUND: This study aimed to explore changes in clinical epidemiology and genotype distribution and their association among hospitalized children with rotavirus gastroenteritis after the introduction of vaccines. METHODS: Between November 2010 and October 2014, hospitalized children with acute gastroenteritis were enrolled. Rotavirus genotypes were confirmed through reverse transcription-polymerase chain reaction (RT-PCR), semi-nested PCR, and sequencing. Clinical information including vaccination status and the modified Vesikari scores were collected. RESULTS: Among 179 children with rotavirus infection, nineteen (10.6 %) were completely vaccinated. During the study period, the number of children between three and 23 months of age decreased significantly compared to the number of children older than 24 months of age (P = 0.010), who showed lower diarrhea severity (duration, P = 0.042; frequency, P = 0.021) but higher vomiting severity (P = 0.007, 0.036) compared to the former. Vaccination status was also significantly associated with lower vomiting severity after adjustment for age (frequency only, P = 0.018). The predominant genotypes were G2P[4] (18.4 %), G1P[8] (14.5 %), and G1P[4]P[8] (12.8 %), and the prevalence of genotypes with uncommon and mixed combinations was more than 50 %. Children infected with G2P[4] strains tended to be older (P = 0.005) and had more severe vomiting (P = 0.018, 0.006) than those with G1P[8]. CONCLUSIONS: Increase in age of infected, hospitalized children was accompanied by change in clinical severity during 2011-2014 after the introduction of vaccines in Seoul. Clinical severity was also associated with vaccination status and genotype. Long-term large scale studies are needed to document the significance of the increase in genotypes of uncommon and mixed combinations.
Asunto(s)
Gastroenteritis/epidemiología , Infecciones por Rotavirus/epidemiología , Distribución por Edad , Preescolar , Diarrea/fisiopatología , Femenino , Gastroenteritis/fisiopatología , Gastroenteritis/prevención & control , Gastroenteritis/virología , Genotipo , Hospitalización , Humanos , Lactante , Masculino , Reacción en Cadena de la Polimerasa , Prevalencia , ARN Viral/genética , Rotavirus/genética , Infecciones por Rotavirus/fisiopatología , Infecciones por Rotavirus/prevención & control , Infecciones por Rotavirus/virología , Vacunas contra Rotavirus/uso terapéutico , Seúl/epidemiología , Análisis de Secuencia de ARN , Índice de Severidad de la EnfermedadRESUMEN
It has been postulated that Helicobacter pylori infection could affect growth and appetite, consequently influencing body weight. Therefore, the association between H. pylori infection and the dietary and anthropometric indicators of nutritional status of a paediatric population were investigated. A total of 525 children (aged 4-16 years) who were referred to the gastroenterology unit of the Sor Maria Ludovica Children's Hospital from Buenos Aires, Argentina, were enrolled and completed an epidemiological questionnaire. H. pylori infection was diagnosed using the ¹³C-urea breath test (¹³C-UBT). Height and weight were assessed for calculation of anthropometric indicators. Energy and macronutrient intakes were estimated by 24 h dietary recall. Data analysis was performed using a χ² test, a Student's t test, a Mann-Whitney U test and linear and logistic regressions. The prevalence of H. pylori infection was 25·1 % (with a mean age of 10·1 (SD 3·1) years). A tendency towards lower energy, carbohydrate, protein and fat intakes was observed in infected patients; however, it was not associated with H. pylori infection in any of the evaluated age groups (4-8, 9-13 and 14-16 years). Underweight, stunting, overweight and obesity were also not associated with the infection. Although height-for-age and BMI-for-age Z scores tended to be lower in infected patients, the differences between H. pylori-positive and H. pylori-negative children were not statistically significant. In conclusion, H. pylori infection was not associated with dietary intake or with anthropometric indicators in the present population of children with gastrointestinal symptoms; however, an increased sample size would be needed to confirm the observed tendency towards lower dietary intake and lower anthropometric indicators of nutritional status in H. pylori-infected children.
Asunto(s)
Fenómenos Fisiológicos Nutricionales Infantiles , Dieta/efectos adversos , Gastroenteritis/fisiopatología , Infecciones por Helicobacter/fisiopatología , Helicobacter pylori/aislamiento & purificación , Estado Nutricional , Adolescente , Desarrollo del Adolescente , Argentina/epidemiología , Índice de Masa Corporal , Niño , Desarrollo Infantil , Preescolar , Estudios de Cohortes , Estudios Transversales , Ingestión de Energía , Femenino , Gastroenteritis/epidemiología , Gastroenteritis/microbiología , Infecciones por Helicobacter/epidemiología , Infecciones por Helicobacter/microbiología , Hospitales Pediátricos , Humanos , Masculino , Sobrepeso/epidemiología , Sobrepeso/etiología , Prevalencia , Estudios Retrospectivos , Delgadez/epidemiología , Delgadez/etiologíaRESUMEN
We analysed the reported duration of incubation and symptomatic periods of norovirus for a dataset of 1022 outbreaks, 64 of which reported data on the average incubation period and 87 on the average symptomatic period. We found the mean and median incubation periods for norovirus to be 32·8 [95% confidence interval (CI) 30·9-34·6] hours and 33·5 (95% CI 32·0-34·0) hours, respectively. For the symptomatic period we found the mean and median to be 44·2 (95% CI 38·9-50·7) hours and 43·0 (95% CI 36·0-48·0) hours, respectively. We further investigated how these average periods were associated with several reported host, agent and environmental characteristics. We did not find any strong, biologically meaningful associations between the duration of incubation or symptomatic periods and the reported host, pathogen and environmental characteristics. Overall, we found that the distributions of incubation and symptomatic periods for norovirus infections are fairly constant and showed little differences with regard to the host, pathogen and environmental characteristics we analysed.
Asunto(s)
Infecciones por Caliciviridae/fisiopatología , Ambiente , Servicios de Alimentación , Gastroenteritis/fisiopatología , Instituciones de Salud , Periodo de Incubación de Enfermedades Infecciosas , ARN Viral/análisis , Infecciones por Caliciviridae/transmisión , Infecciones por Caliciviridae/virología , Transmisión de Enfermedad Infecciosa , Enfermedades Transmitidas por los Alimentos , Gastroenteritis/virología , Humanos , Modelos Lineales , Norovirus/genética , Estaciones del Año , Factores de TiempoRESUMEN
OBJECTIVES: Because rotavirus gastroenteritis is associated with high morbidity and mortality especially in developing countries, it is necessary to develop antirotavirus drugs for the treatment of rotavirus infection. Previous studies have demonstrated that cyclosporin A (CsA) has antiviral properties against rotavirus. Its effect has not yet been evaluated against rotavirus diarrheal disease. The aim of this study was to assess the anti-rotavirus efficacy of CsA in neonatal mice after induction of rotavirus diarrhea. METHODS: Suckling mice were inoculated with murine rotavirus. On the onset of diarrhea, mice were given different concentrations of CsA. To evaluate the effects of CsA on reduction of rotavirus diarrhea, diarrhea score, fecal virus shedding, and pathological lesion change in the small intestine, messenger RNA (mRNA) expression levels in the small intestine and spleen of mice were measured for type I interferon (IFN-α and IFN-ß), inflammation-related cytokines (interleukin [IL]-8, IL-10, IFN-γ, and tumor necrosis factor-α), and inflammatory signaling pathways (p38, c-Jun N-terminal kinase, activator protein-1, and nuclear factor-kappa B). RESULTS: Among virus-inoculated and CsA-treated groups, a dose of 5 mg · kg⻹ · day⻹ of CsA inhibited diarrhea and improved fecal virus shedding and intestinal lesion changes. IFN-ß mRNA expression was significantly increased in rotavirus-induced diarrhea mice treated with 5 mg · kg⻹ · day⻹ of CsA, whereas the mRNA expression levels of inflammation-related cytokines (IL-8, IL-10, IFN-γ, and tumor necrosis factor-α) and inflammatory signaling pathways (p38, c-Jun N-terminal kinase, activator protein-1, and nuclear factor-kappa B) were markedly decreased. Antiviral effects of CsA were dose dependent. CONCLUSIONS: CsA can inhibit rotavirus infection in neonatal mice through its antiviral properties. The mechanism for this may be through CsA suppression of inflammation by viral inhibition in animal models.
Asunto(s)
Antivirales/uso terapéutico , Ciclosporina/uso terapéutico , Diarrea/prevención & control , Modelos Animales de Enfermedad , Gastroenteritis/tratamiento farmacológico , Infecciones por Rotavirus/tratamiento farmacológico , Rotavirus/efectos de los fármacos , Animales , Animales Recién Nacidos , Antivirales/administración & dosificación , Ciclosporina/administración & dosificación , Citocinas/genética , Citocinas/metabolismo , Diarrea/etiología , Relación Dosis-Respuesta a Droga , Gastroenteritis/patología , Gastroenteritis/fisiopatología , Gastroenteritis/virología , Regulación de la Expresión Génica/efectos de los fármacos , Mediadores de Inflamación/metabolismo , Mucosa Intestinal/efectos de los fármacos , Mucosa Intestinal/inmunología , Mucosa Intestinal/metabolismo , Mucosa Intestinal/patología , Intestino Delgado/efectos de los fármacos , Intestino Delgado/inmunología , Intestino Delgado/metabolismo , Intestino Delgado/patología , Ratones Endogámicos BALB C , Distribución Aleatoria , Rotavirus/crecimiento & desarrollo , Rotavirus/inmunología , Rotavirus/aislamiento & purificación , Infecciones por Rotavirus/patología , Infecciones por Rotavirus/fisiopatología , Infecciones por Rotavirus/virología , Organismos Libres de Patógenos Específicos , Bazo/efectos de los fármacos , Bazo/inmunología , Bazo/metabolismo , Esparcimiento de Virus/efectos de los fármacosRESUMEN
OBJECTIVE: Water is an essential nutrient overlooked in many cross-cultural studies of human nutrition. The present article describes dietary water intake patterns among forager-horticulturalist adults in lowland Bolivia, compares daily intake with international references and examines if variation in how people acquire water relates to gastrointestinal illness. DESIGN: Cross-sectional observational study used survey, anthropometric and qualitative methods with Tsimane' adults selected by age and sex stratification sampling in one community. SETTING: Research occurred in one Tsimane' village in the Beni department, Bolivia with limited access to clean water. The 24 h diet and health recalls were conducted in July-August 2012 and qualitative interviews/ethnographic observation in September-October 2013. SUBJECTS: Forty-five Tsimane' household heads (49% men) took part in the first data collection and twenty-two Tsimane' (55% men) were included in the follow-up interviews. RESULTS: Men and women reported consuming 4·9 litres and 4·4 litres of water daily from all dietary sources, respectively. On average, water from foods represented 50 % of total water intake. Thirteen per cent of participants reported symptoms of gastrointestinal illness. In a logistic regression model adjusted for age, BMI, sex and raw water consumed, each percentage increase in water obtained from foods was associated with a reduced risk of gastrointestinal illness (OR=0·92; 95% CI 0·85, 0·99). CONCLUSIONS: Both total water intake and percentage of water from foods were higher than averages in industrialized countries. These findings suggest that people without access to clean water may rely on water-rich foods as a dietary adaptation to reduce pathogen exposures.